Frontotemporal Dementia Clinical Trials

Find clinical trials for frontotemporal dementia. Search for frontotemporal dementia clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 32

Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 TrialLemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

Recruiting

Sponsor:

Nova Scotia Health Authority

Location:

Halifax

Code:

NCT06093126

Conditions

Insomnia

Dementia

Frontotemporal Dementia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Lemborexant 5 MG

A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesA Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes

Recruiting

PHASE1

PHASE2

Sponsor:

Passage Bio, Inc.

Location:

Philadelphia PA, Houston TX, Toronto, Montreal

Code:

NCT04747431

Conditions

Frontotemporal Dementia

FTD

FTD-GRN

Dementia Frontotemporal

C9orf72

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

PBFT02

Diagnosis of Alzheimer's Disease Using Event Related PotentialsDiagnosis of Alzheimer's Disease Using Event Related Potentials

Recruiting

Sponsor:

VA Boston Healthcare System

Location:

Jamaica Plain MA

Code:

NCT02957227

Conditions

Mild Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

No intervention is part of this study but patients use an EEG device during observational data collection.

Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)

Recruiting

PHASE1

PHASE2

Sponsor:

Prevail Therapeutics

Location:

Maitland FL, Orlando FL, Philadelphia PA

Code:

NCT04408625

Conditions

Frontotemporal Dementia

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

LY3884963

Methylprednisolone

Optional Sirolimus

Optional Prednisone

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

Recruiting

Sponsor:

Sanofi

Location:

Chicago IL, Cincinnati OH, Columbus OH, Philadelphia PA

Code:

NCT06192576

Conditions

Niemann-Pick Diseases

Acid Sphingomyelinase Deficiency

Eligibility Criteria

Sex: All

Age: 0 - 2

Healthy Volunteers: Not accepted

Interventions

Olipudase alfa

Subgenual Cingulate Deep Brain STIMulation for Apathetic Behavioral Variant FRONtotemporal DementiaSubgenual Cingulate Deep Brain STIMulation for Apathetic Behavioral Variant FRONtotemporal Dementia

Recruiting

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT05699330

Conditions

Frontotemporal Dementia

Deep Brain Stimulation

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Bilateral subgenual cingulate deep brain stimulation (SGC DBS)

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal DementiaInvestigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Recruiting

Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Location:

Bethesda MD

Code:

NCT03225144

Conditions

Frontotemporal Dementia

Amyotrophic Lateral Sclerosis

Progressive Supranuclear Palsy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative ModelingImproving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

Recruiting

Sponsor:

University Health Network, Toronto

Location:

North York, Toronto

Code:

NCT06529744

Conditions

Dementia

Alzheimer Disease

Dementia with Lewy Bodies

Vascular Dementia

Frontotemporal Dementia

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

UCB Transplant of Inherited Metabolic Diseases with Administration of Intrathecal UCB Derived Oligodendrocyte-Like CellsUCB Transplant of Inherited Metabolic Diseases with Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Recruiting

PHASE1

Sponsor:

Joanne Kurtzberg, MD

Location:

Durham NC

Code:

NCT02254863

Conditions

Adrenoleukodystrophy

Batten Disease

Mucopolysaccharidosis II

Leukodystrophy, Globoid Cell

Leukodystrophy, Metachromatic

Eligibility Criteria

Sex: All

Age: 1 - 22

Healthy Volunteers: Not accepted

Interventions

DUOC-01

Stories in the Moment: Dance Program for People Living With DementiaStories in the Moment: Dance Program for People Living With Dementia

Recruiting

Sponsor:

DanceStream Projects

Location:

New York NY

Code:

NCT06221202

Conditions

Dementia

Mild Cognitive Impairment

Alzheimer Disease

Lewy Body Disease

Frontotemporal Dementia

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Stories in the Moment Dance Program - Online